|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：C210010 |
| 產(chǎn)品名稱(chēng)：Cu-ATSM |
| 產(chǎn)品CAS：68341-09-3 |
| 規(guī)格含量：50mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
C210010 |
| 名稱(chēng): |
Cu-ATSM |
| 別名: |
Coordination Compound; [[2,2'-(1,2-Dimethyl-1,2-ethanediylidene)bis[N-methylhydrazinecarbothioamidato]](2-)-N2,N2',S,S']-, (SP-4-2)Copper; [[2,2 Prime-(1,2-Dimethyl-1,2-ethanediylidene)bis[N-methylhydrazinecarbothioamidato]]] copper |
| CAS號(hào): |
68341-09-3 |
| 分子式: |
C?H??CuN?S? |
| 分子量: |
321.91 |
| 類(lèi)別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Cu-ATSM is preclinically used as a potential therapy for ALS (amyotrophic lateral sclerosis). A potential anti-Alzheimer's agent. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
